Evidence map›Paper›PMID 42530231›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2026

Hierarchical Peptide Functionalized Titania Nanotubes: Improving Stability, Promoting Osteogenesis, and Reducing Infection Risk.

Ramesh Singh, Ketul C Popat

Abstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Fabrication of TiOMicromachines · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ramesh SinghDepartment of Bioengineering, George Mason University, Fairfax, Virginia, USA.ORCID https://orcid.org/0000-0002-2874-4971
Ketul C PopatDepartment of Bioengineering, George Mason University, Fairfax, Virginia, USA.ORCID https://orcid.org/0000-0002-2417-7789

Funding

Nanostructured Surfaces With Improved HemocompatibilityR21EB033511 · NIBIB · GEORGE MASON UNIVERSITY · PI KIPPER, MATTHEW, POPAT, KETUL CHANDRAKANT · 2022 to 2023
$410k
NIBIB NIH HHS R21 EB033511NIH HHS 1R21EB033511-01
6 · The paper itself

Abstract

In this study, a hierarchical surface functionalization strategy was developed that combines engineering of titania nanotubes (TiNTs) on the titanium surface, followed by dual-mode peptide functionalization. Fmoc-FF-OH dipeptide was first covalently anchored onto the TiNT surface, then a secondary layer of the self-assembling FF dipeptide was physically deposited. This technique harnesses the strength of covalent bonds and the extensive surface coverage provided by self-assembling peptides to create a long-lasting, bioactive, and functional surface that promotes superior biocompatibility. The nanotubular topography and peptide-mediated biochemical cues recreate an extracellular matrix-like microenvironment, supporting stem cell adhesion, proliferation, and osteogenic differentiation. Additionally, the self-assembling peptide significantly reduced bacterial adhesion compared to unmodified titanium, demonstrating a marked reduction in bacterial adhesion and early biofilm formation in vitro. Overall, this multifunctional approach combines nanotopographical engineering with peptide-based bioactivity to enhance implant osseointegration and prevent implant-associated infections, offering a promising strategy for next-generation titanium biomedical devices.

Indexed as

NanotubesOsteogenesisPeptidesTitaniumAnimalsBacterial AdhesionBiofilmsCell AdhesionCell DifferentiationCell ProliferationHumansSurface PropertiesPeptidesTitaniumtitanium dioxideantibacterialosteogenesispeptide self‐assemblysurface biofunctionalizationtitania nanotubes

Identifiers

PMID42530231
PMCPMC13630414

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.